ZyVersa Therapeutics, Inc. ZVSA
0.00 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
0.29 +0.29 +28,800.00%
After hours · Nov 3, 4:00 PM ET
0.0415 Day range 0.05
0.001 52-week range 0.30
- YTD
- -99.25%
- 1 year
- -99.26%
Financial health
Altman Z-Score
-23.21 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.0×
FY 2020 5y median -0.1× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B -0.1×
FY 2020 5y median 0.1× FY 2025
P/FCF -156×
FY 2020 5y median -9.5× FY 2025
EV/EBITDA -27.6×
FY 2020 5y median -0.6× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -0.6%
FY 2020 5y median -10.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE 0.2%
FY 2020 5y median -14.0% FY 2025
ROIC 0.1%
FY 2020 5y median -11.9% FY 2025
ROA -7.2%
FY 2020 5y median -444.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income 99.9%
FY 2020 FY 2025
EPS (diluted) 50.7%
FY 2020 FY 2025
Free Cash Flow 32.3%
FY 2020 FY 2025
Financial Health
Current Ratio 0.0×
FY 2020 5y median 0.2× FY 2025
Quick Ratio 0.0×
FY 2020 5y median 0.2× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 4.0×
FY 2020 5y median 0.0× FY 2025
Interest Coverage -13.3×
FY 2020 5y median -13.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31